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Abstract
Esophagitis is described as an inflammation of the esophagus and can result from multiple
etiologies. Esophageal squamous cell carcinoma (ESCC), presenting as diffuse esophagitis in
the absence of a mass or lesion, is rare. We present a case of a 61-year-old man who presented to the gastroenterology clinic for dysphagia and heartburn of 3 months duration. The patient had lost about 15 pounds unintentionally over 6 months. The patient underwent esophagogastroduodenoscopy, which revealed significant diffuse Grade 4 esophagitis without any
overt bleeding. Random biopsies were taken with cold forceps from proximal, middle, and
distal esophageal segments because of the striking endoscopic appearance. Histopathology
revealed high-grade dysplasia and carcinoma in situ. The patient underwent endoscopic ultrasound (EUS) of the esophagus, which revealed a focal lesion. EUS-guided fine-needle aspiration showed squamous cell carcinoma of the esophagus. ESCC usually presents as a mass
or a gross lesion seen on endoscopy. However, it rarely presents as severe diffuse esophagitis
seen on routine endoscopy. From our observation, it would be reasonable for physicians to
bear this unusual endoscopic presentation in mind and perform multiple random biopsies if
encountered with such a case to rule out the possibility of any underlying malignancy.
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Introduction

Esophagitis is a well-known condition described as an inflammation of the esophagus.
There are various etiologies of esophagitis, including infectious, noninfectious, chemical, medication-induced, and gastroesophageal reflux disease. These etiologies commonly involve the
distal esophagus. The history and physical findings may vary according to the underlying
etiology. The most common symptoms of esophagitis include heartburn, dyspepsia, nausea,
bloating, and fullness. Less common clinical features of esophagitis include dysphagia and odynophagia. According to a study in the USA, among patients with symptoms of gastroesophageal
reflux, around 34% were found to have reflux esophagitis on esophagogastroduodenoscopy
(EGD) [1]. Savary-Miller is the most widely used endoscopic grading system used to grade the
degree of esophagitis. Common complications of GERD include ulceration, stricture formation,
and Barrett esophagus, which can eventually progress to esophageal adenocarcinoma.
Esophageal cancer is associated with a high mortality and is the eighth most common cause
of cancer in the world [2]. According to statistical analysis done by the American Cancer Society
16, 170 deaths are expected to result from esophageal cancer [3]. Poor nutritional status, low
intake of vegetables and fruit, and consumption of hot beverages are thought to contribute to
squamous cell carcinoma of the esophagus in the developing countries, while smoking and
excessive alcohol consumptions are thought to contribute to the development of 90% of total
cases of squamous cell carcinoma of the esophagus in the USA and several Western countries
[4]. According to a study done in 22 centers in North America, Europe, and Australia, it the incidence of adenocarcinoma of the esophagus has increased significantly over the last 20 years [5].
The same study revealed that the average increase in the incidence has been from 8.7 to 17.5%.
Esophageal squamous cell carcinoma (ESCC), presenting as diffuse esophagitis in the
absence of a mass or lesion, is rare. We present a case of severe diffuse esophagitis in a patient
with grade 4 esophagitis and which was later found to be ESCC on the pathology of the routine
biopsies.
Case Presentation

We present a case of 61-year-old man who presented to the outpatient gastroenterology
clinic for dysphagia of 3 months duration. He complained of solid food getting stuck in his
chest and had mild discomfort with liquids as well. He also reported some heartburn and acid
reflux which had not responded to over-the-counter antacids and ranitidine. He reported
unintentional weight loss from 200 pounds to 185 pounds over 6 months. There was no
abdominal pain, nausea, vomiting, constipation, fever, and early satiety or appetite changes,
hematemesis, hematochezia, or melena. He had a prior history of hypertension, hyperlipidemia. He had an inguinal hernia repair and left knee surgery in the past. He also had a
screening colonoscopy a few years prior to his presentation and was unremarkable except
right-sided diverticulosis and nonbleeding internal hemorrhoids.
He was a current smoker and admitted smoking cigarettes everyday but denied using alcohol
except on social occasions or illicit drugs. He did not have a family history of liver, stomach, or
colon cancer. His medications included aspirin, atorvastatin, carvedilol, and amlodipine.
On examination, he was afebrile, and his vital signs were within normal limits. He was
alert, fully oriented, and communicative. The abdomen was soft, nontender, nondistended
with normal bowel sounds. Spleen was palpable on physical examination. Cervical and supraclavicular lymph nodes were not palpable. Rest of the physical examination was unremarkable.
Patient complete blood cell count, basic metabolic profile, and liver function tests were
ordered. They were unremarkable.
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Fig. 1. Endoscopic photograph showing grade 4
esophagitis.

Fig. 2. Histopathology of the distal esophagus showing high-grade dysplasia and carcinoma in situ
(original magnification is ×100).

Patient underwent EGD which revealed significant Grade 4 esophagitis in the entire
esophagus. This has been shown in Figure 1.
Random biopsies were taken with a cold forceps from 3 different segments of the
esophagus because of the high-risk clinical feature of the patient and were sent for further
analysis. Sample was also sent for Helicobacter pylori testing. Histopathology revealed highgrade dysplasia and carcinoma in situ. This has been shown in Figures 2 and 3.
Patient was referred to a tertiary care hospital center for further management. Patient
underwent endoscopic ultrasound of esophagus which revealed a focal lesion. Endoscopic
ultrasound-guided fine-needle aspiration showed ESCC. Oncology was consulted for further
management.
Discussion

Various factors contribute to the development of ESCC. Risk factors for the development
of ESCC include hereditary factors, smoking and alcohol consumptions, high-temperature
beverages, a diet low in vegetables and fruits, preexisting esophageal diseases such as
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Fig. 3. Magnified histopathology of the distal esophagus showing high-grade dysplasia and carcinoma
in situ (original magnification is ×400).

achalasia and caustic strictures, prior partial gastrectomy, atrophic gastritis, and human
papillomavirus [6–9]. The prevalence of ESCC increases with age and peaks around seventh
decade of life [10]. The incidence of esophageal SCC is higher in the African-American population and is more common in males than females [11].
Dysphagia and weight loss are the most common presenting symptoms of squamous cell
carcinoma. The patient may also present with epigastric or retrosternal pain, regurgitation,
persistent cough, hoarseness, and chronic gastrointestinal blood loss. Physical examination
of the patient will be unremarkable unless esophageal cancer has metastasized. Our patient
was a 61-year-old male who was an active smoker, presented with the complaint of dysphagia,
heartburn, and weight loss.
Endoscopy with biopsy is the primary diagnostic tool. Endoscopic findings of early ESCC
include irregular mucosa focal red area, small white patch, erosion, superficial plaques,
nodules, or ulceration. The advanced lesion usually appears as stricture, ulceration, and large
mucosal mass. White light endoscopy has a 62% sensitivity and specificity of 79% in detecting
high-grade dysplasia and squamous cell cancer [12]. Our patient only had inflammation as
the gross finding on EGD. Multiple random biopsies should be performed in patients with
high-risk clinical features, risk factors, and endoscopic findings of severe diffuse esophagitis.
Lugol chromoendoscopy is a procedure in which Lugol’s iodine is instilled into the gastrointestinal tract at the time of endoscopy. According to a study, the detection rate of esophageal dysplasia and early ESCC was 13.7% in the group of patients who underwent chromoendoscopy compared to 10.6% in the group of patients who underwent routine endoscopy
(p = 0.003) [13]. We did not perform lugol chromoendoscopy for our patient.
A multidisciplinary approach is needed to manage patients with ESCC. According to Japan
Esophageal Society (JES), endoscopic therapy can be considered in patients with mucosal
tumors involving the epithelium and lamina propria mucosae. Surgical management can be
considered in patient with localized disease. Preoperative chemoradiation therapy can be
offered to patients with advanced noncervical esophageal cancer [14].
Despite advances in treatment modalities for esophageal cancer, the overall 5-year
survival rate of patients with esophageal cancer is still 15–25% worldwide [15]. Tumor size,
tumor staging, node staging, and tumor differentiation are independent prognostic factors
affecting the prognosis of ESCC patients [16].
Squamous cell carcinoma usually presents as a mass or a lesion seen on endoscopy.
However, it rarely presents as severe diffuse esophagitis found on routine endoscopy. From
our observation, we conclude it would be reasonable for physicians to bear this unusual endoscopic presentation in mind and perform multiple random biopsies if encountered with such
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a case to rule out the possibility any an underlying malignancy which if missed could have
life-threatening consequences.
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